|
Session 162
Poster Abstracts
Impact of HBV or HCV on Disease Progression in HIV-Infected Persons
Tuesday, 1 - 4 pm
Poster Hall |
919
 |
HBV/HCV Prevalence in an Urban South African HIV Clinic: Implications for Antiretroviral Care in the Resource-limited Setting
Cynthia Firnhaber*1, A Reyneke1, L Azzoni2, B Molope1, I Jaffray1, D Van Amesterdam1, A Di Bisceglie1, L Montaner2, and I Sanne1
1Univ of Witswatersrand, Johannesburg, South Africa and 2Wistar Inst, Philadelphia, PA, US |
920
|
Hepatitis B Virus Co-infection Affects Baseline HIV Parameters and HAART-related Hepatotoxicity Risk in an HIV-infected Nigerian Cohort
J Idoko1, S Meloni2, M Muazu1, C Hawkins3, B Badung1, N Gwamzi1, P Kanki2, R Murphy3, E Ekong4, and Chloe Thio*5
1Jos Univ Teaching Hosp, Plateau State, Nigeria; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3Northwestern University, Chicago, IL, USA; 4Harvard-PEPFAR Prgm, Lagos, Nigeria; and 5Johns Hopkins Univ, Baltimore, MD, US |
921
|
Impact of Hepatitis C Virus on HIV-infected Individuals in Nigeria
N Gwamzi1, C Hawkins2, S Meloni3, M Muazu1, B Badung1, R Chung4, P Kanki3, E Ekong5, J Idoko1, and Camilla Graham*6
1Jos Univ Teaching Hosp, Nigeria; 2Northwestern University, Chicago, IL, USA; 3Harvard Sch of Publ Hlth, Boston, MA, US; 4Massachusetts Gen Hosp, Boston, US; 5Military Reference Hosp, Lagos, Nigeria; and 6Beth Israel Deaconess Med Ctr, Boston, MA, US |
| 922 |
Effect of Hepatitis C Virus and HIV Infections on Mortality among Illicit Drug Users
Jason Grebely*1, J Raffa2, B Conway1, C Lai3, M Krajden4, M Tyndall1,3, and M Tyndall1,3
1Univ of British Columbia, Vancouver, Canada; 2Univ of Waterloo, Canada; 3BC Ctr for Excellence in HIV/AIDS, Vancouver, Canada; and 4BC Ctr for Disease Control, Vancouver, Canada |
| 923 |
HCV/HIV-co-infected Drug Users Are at Increased Risk of Dying from Hepatitis-related Death in the HAART Era, Compared with HCV-mono-infected Drug Users
Maria Prins*1, C Smit1, C van den Berg2, R Geskus1, B Berkhout2, and R Coutinho3
1Hlth Svc Amsterdam, The Netherlands; 2Academic Med Ctr, Amsterdam, The Netherlands; and 3Ctr for Infectious Disease Control, Bilthoven, The Netherlands |
| 924 |
Characteristics of HIV/HCV-co-infected Patients with Persistent Normal Transaminase Levels
Luz Martin-Carbonero*1, P Barreiro1, I Maida2, M Nuņez1, C Castellares1, J Gonzalez-Lahoz1, and V Soriano1
1Hosp Carlos III, Madrid, Spain and 2Univ of Sassari, Italy |
| 925 |
Low CD4 Cell Counts Are Associated with Higher Hepatitis C Viral Loads in the Swiss HIV Cohort Study
Andri Rauch*1, S Gaudieri2, M Cavassini3, R Weber4, D Nolan2, I James2, and H Furrer1
1Univ Hosp, Berne, Switzerland; 2CCIBS, Murdoch Univ, Perth, Australia; 3Univ of Lausanne, Switzerland; and 4Univ Hosp, Zurich, Switzerland |
| 926 |
Steatosis in HIV/HVC-co-infected Patients
A Mohsen1, D. O'Shea*2, B Portmann3, O Barry2, H Tuite2, C Donnelly2, C Bergin2, and S Norris2
1Chelsea and Westminster Hosp, London, UK; 2St James's Hosp, Dublin, Ireland; and 3Inst of Liver Studies, King's Coll Hosp, London, UK |
| 927 |
Hepatitis C Co-infection Decreases Total Cholesterol and Triglyceride Levels and Lessens the Effect of Antiretroviral Medications on Lipids
Heidi Crane* and M Kitahata
Univ of Washington, Seattle, US |
928
|
Plasmacytoid Dendritic Cells Expressing CD40 and CD83 Are Increased in HIV-1 Patients with GBV-C Co-infection
Nupur Bhatnagar*, M Moenkemeyer, H Hong, R Schmidt, and H Heiken
Hannover Med Sch, Germany |
929
|
No Increased Incidence of Transaminitis among HIV Patients with Occult Hepatitis B
Vincent Lo Re III*1, J Kostman1, I Frank1, R Localio1, J Dockter2, J Linnen2, C Giachetti2, P Tebas1, B Strom1, and R Gross1
1Univ of Pennsylvania Sch of Med, Philadephia, US and 2Gen-Probe, San Diego, CA, US |
|
